NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗青光眼藥的全球市場:至2030年的機會及策略 - COVID-19影響與復甦

Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

出版商 The Business Research Company 商品編碼 980095
出版日期 內容資訊 英文 290 Pages
商品交期: 2-3個工作天內
價格
抗青光眼藥的全球市場:至2030年的機會及策略 - COVID-19影響與復甦 Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery
出版日期: 2020年12月28日內容資訊: 英文 290 Pages
簡介

本報告提供全球抗青光眼藥市場的相關調查,市場規模和預測,趨勢和策略,成長及阻礙因素,COVID-19的影響,各產品類型、疾病類型、處方類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 目錄

第3章 圖的清單

第4章 表格的清單

第5章 報告結構

第6章 簡介

    • 各地區市場區隔
    • 各產品類型市場區隔
    • 各疾病類型市場區隔
    • 各處方類型市場區隔

第7章 市場特徵

  • 市場定義
  • 各產品類型市場區隔
    • Alpha受體激動劑
    • β- 阻斷劑
    • 前列腺素類似體
    • 並用藥
    • 其他
  • 各疾病類型市場區隔
    • 開放性青光眼
    • 隅角閉鎖性青光眼
    • 正常張力青光眼
    • 先天性青光眼
    • 其他類型的青光眼
  • 各處方類型市場區隔
    • OTC藥
    • 處方藥

第8章 市場趨勢與策略

  • 青光眼治療的Rho激化酵素抑制劑
  • 聯合治療的開發
  • 對持續輸送抗青光眼藥的投資
  • 抗青光眼藥的人工智慧的投資

第9章 COVID-19的影響

  • 簡介
  • 消費者意識
  • 遠程醫療服務轉移的醫療保健提供者

第10章 市場規模與成長

  • 市場規模
  • 市場成長:銷售額成果(2015-2019)
    • 市場成長要素
    • 阻礙市場要素
  • 市場成長:銷售額預測(2019-2023,2025F,2030F)

第11章 市場區隔

  • 市場銷售額成果、預測:各疾病類型(2015-2019,2023F,2025F,2030F)
    • 開放性青光眼
    • 隅角閉鎖性青光眼
    • 正常張力青光眼
    • 其他類型的青光眼
    • 先天性青光眼
  • 市場銷售額成果、預測:各產品類型(2015-2019,2023F,2025F,2030F)
    • 前列腺素類似體
    • 並用藥
    • 其他
    • β- 阻斷劑
    • Alpha受體激動劑
  • 市場銷售額成果、預測:各類型(2015-2019,2023F,2025F,2030F)
    • 處方藥
    • OTC藥

第12章 市場分析:各地區/國家

  • 市場成果、預測:各區域銷售額(2015-2019,2023F,2025F,2030F)
  • 市場成果、預測:各國銷售額(2015-2019,2023F,2025F,2030F)

第13章 亞太地區的抗青光眼藥市場

第14章 西歐的抗青光眼藥市場

第15章 東歐的抗青光眼藥市場

第16章 北美的抗青光眼藥市場

第17章 南美的抗青光眼藥市場

第18章 中東的抗青光眼藥市場

第19章 非洲的抗青光眼藥市場

第20章 全球抗青光眼藥市場競爭情形環境

  • 企業簡介
  • Allergen Plc.
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
  • Akorn
  • Pfizer

第21章 市場上主要合併和收購

第22章 開發平台分析

第23章 機會及策略

  • 2023年的市場:提供最新機會的國家
  • 2023年的市場:提供最新機會的市場區隔
  • 2023年的市場:成長策略
    • 市場趨勢為基礎的策略
    • 競爭的策略

第24章 結論、建議

  • 結論
  • 建議

第25章 附錄

目錄

Antiglaucoma Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the antiglaucoma drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global antiglaucoma drugs market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by product type, by condition type and segmentation by prescription type.

Market Characteristics - The market characteristics section of the report defines and explains the antiglaucoma drugs market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global antiglaucoma drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 - This section describes the impact of COVID-19 on the antiglaucoma drugs market.

Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2015-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size (2019), historic (2015-2019) and forecast (2019-2023), (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global antiglaucoma drugs market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Pipeline Analysis - This section gives brief idea on antiglaucoma drugs in pipeline.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for antiglaucoma drugs companies in terms of product offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global Antiglaucoma Drugs market is segmented into -

By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others

By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma

By Prescription Type: OTC Drugs; Prescription Drugs

Companies Mentioned: Allergen Plc.; Novartis AG; Santen Pharmaceutical Co., Ltd.; Akorn; Pfizer

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Antiglaucoma Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. Segmentation By Product Type
    • 6.1.3. Segmentation By Condition Type
    • 6.1.4. Segmentation By Prescription Type

7. Antiglaucoma Drugs Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Product Type
    • 7.2.1. Alpha Agonist
    • 7.2.2. Beta Blockers
    • 7.2.3. Prostaglandin Analogs
    • 7.2.4. Combined Medication
    • 7.2.5. Others
  • 7.3. Market Segmentation By Disease Condition Type
    • 7.3.1. Open-Angle Glaucoma
    • 7.3.2. Angle-Closure Glaucoma
    • 7.3.3. Normal-Tension Glaucoma
    • 7.3.4. Congenital Glaucoma
    • 7.3.5. Other Types Of Glaucoma
  • 7.4. Market Segmentation By Prescription Type
    • 7.4.1. OTC Drugs
    • 7.4.2. Prescription Drugs

8. Antiglaucoma Drugs Market Trends And Strategies

  • 8.1. Rho-Kinase Inhibitors In Glaucoma Treatment
  • 8.2. Development Of Combination Therapies
  • 8.3. Investment In Anti-Glaucoma Drugs With Sustained Delivery
  • 8.4. Investment In Artificial Intelligence For Anti-Glaucoma Drugs

9. Covid-19 Impact On The Antiglaucoma Drugs Market

  • 9.1. Introduction
  • 9.2. Consumer Perception
  • 9.3. Healthcare Providers Shifting Towards Telehealth Services

10. Global Antiglaucoma Drugs Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2019, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2019
    • 10.2.2. Aging Population
    • 10.2.3. Restraints Of The Market 2015-2019
  • 10.3. Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2019 - 2023
    • 10.3.2. Restraints On The Market 2019 - 2023

11. Global Antiglaucoma Drugs Market Segmentation

  • 11.1. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Open-Angle Glaucoma
    • 11.1.2. Angle-Closure Glaucoma
    • 11.1.3. Normal-Tension Glaucoma
    • 11.1.4. Other Types Of Glaucoma
    • 11.1.5. Congenital Glaucoma
  • 11.2. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.2.1. Prostaglandin Analogs
    • 11.2.2. Combined Medication
    • 11.2.3. Others
    • 11.2.4. Beta Blockers
    • 11.2.5. Alpha Agonist
  • 11.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
    • 11.3.1. Prescription Drugs
    • 11.3.2. OTC Drugs

12. Antiglaucoma Drugs Market, Regional And Country Analysis

  • 12.1. Global Antiglaucoma Drugs Market, By Region, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Antiglaucoma Drugs Market, By Country, Historic and Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Antiglaucoma Drugs Market

  • 13.1. Asia-Pacific Antiglaucoma Drugs Market Overview
    • 13.1.1. Region Information
    • 13.1.2. COVID Impact
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.3. Asia-Pacific Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.4. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.5. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.6. Asia-Pacific Antiglaucoma Drugs Market: Country Analysis
  • 13.7. China Antiglaucoma Drugs Market
  • 13.8. China Antiglaucoma Drugs Market Overview
    • 13.8.1. Country Information
    • 13.8.2. COVID Impact
    • 13.8.3. Market Information
    • 13.8.4. Background Information
    • 13.8.5. Government Initiatives
    • 13.8.6. Regulations
    • 13.8.7. Regulatory Bodies
    • 13.8.8. Major Associations
    • 13.8.9. Taxes levied
    • 13.8.10. Corporate Tax Structure
    • 13.8.11. Investments
    • 13.8.12. Major Companies
  • 13.9. China Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.10. China Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.11. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.12. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.13. India Antiglaucoma Drugs Market
  • 13.14. India Antiglaucoma Drugs Market Overview
    • 13.14.1. Country Information
    • 13.14.2. COVID Impact
    • 13.14.3. Market Information
    • 13.14.4. Background Information
    • 13.14.5. Government Initiatives
    • 13.14.6. Regulations
    • 13.14.7. Regulatory Bodies
    • 13.14.8. Major Associations
    • 13.14.9. Taxes levied
    • 13.14.10. Corporate Tax Structure
    • 13.14.11. Investments
    • 13.14.12. Major Companies
  • 13.15. India Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.16. India Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.17. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.18. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.19. Japan Antiglaucoma Drugs Market
  • 13.20. Japan Antiglaucoma Drugs Market Overview
    • 13.20.1. Country Information
    • 13.20.2. COVID Impact
    • 13.20.3. Market Information
    • 13.20.4. Background Information
    • 13.20.5. Government Initiatives
    • 13.20.6. Regulations
    • 13.20.7. Regulatory Bodies
    • 13.20.8. Major Associations
    • 13.20.9. Taxes levied
    • 13.20.10. Corporate Tax Structure
    • 13.20.11. Investments
    • 13.20.12. Major Companies
  • 13.21. Japan Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.22. Japan Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.23. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.24. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.25. Australia Antiglaucoma Drugs Market
  • 13.26. Australia Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.27. Australia Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.28. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.29. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.30. Indonesia Antiglaucoma Drugs Market
  • 13.31. Indonesia Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.32. Indonesia Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.33. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.34. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.35. South Korea Antiglaucoma Drugs Market
  • 13.36. South Korea Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 13.37. South Korea Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 13.38. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 13.39. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

14. Western Europe Antiglaucoma Drugs Market

  • 14.1. Western Europe Antiglaucoma Drugs Market Overview
    • 14.1.1. Region Information
    • 14.1.2. COVID Impact
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government Initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.3. Western Europe Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.4. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.5. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.6. Western Europe Antiglaucoma Drugs Market: Country Analysis
  • 14.7. UK Antiglaucoma Drugs Market
  • 14.8. UK Antiglaucoma Drugs Market Overview
    • 14.8.1. Region Information
    • 14.8.2. COVID Impact
    • 14.8.3. Market Information
    • 14.8.4. Background Information
    • 14.8.5. Government Initiatives
    • 14.8.6. Regulations
    • 14.8.7. Major Associations
    • 14.8.8. Taxes Levied
    • 14.8.9. Corporate Tax Structure
    • 14.8.10. Investments
    • 14.8.11. Major Companies
  • 14.9. UK Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.10. UK Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.11. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.12. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.13. Germany Antiglaucoma Drugs Market
  • 14.14. Germany Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.15. Germany Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.16. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.17. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.18. France Antiglaucoma Drugs Market
  • 14.19. France Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 14.20. France Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 14.21. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 14.22. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Antiglaucoma Drugs Market

  • 15.1. Eastern Europe Antiglaucoma Drugs Market Overview
    • 15.1.1. Region Information
    • 15.1.2. COVID Impact
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Government Initiatives
    • 15.1.6. Regulations
    • 15.1.7. Regulatory Bodies
    • 15.1.8. Major Associations
    • 15.1.9. Taxes Levied
    • 15.1.10. Corporate Tax Structure
    • 15.1.11. Investments
    • 15.1.12. Major Companies
  • 15.2. Eastern Europe Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.3. Eastern Europe Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.4. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.5. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.6. Eastern Europe Antiglaucoma Drugs Market: Country Analysis
  • 15.7. Russia Antiglaucoma Drugs Market
  • 15.8. Russia Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 15.9. Russia Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 15.10. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.11. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

16. North America Antiglaucoma Drugs Market

  • 16.1. North America Antiglaucoma Drugs Market Overview
    • 16.1.1. Region Information
    • 16.1.2. COVID-19 Impact
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Tax Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.3. North America Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.4. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.5. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.6. North America Antiglaucoma Drugs Market: Country Analysis
  • 16.7. USA Antiglaucoma Drugs Market Overview
    • 16.7.1. Country Information
    • 16.7.2. COVID-19 Impact
    • 16.7.3. Market Information
    • 16.7.4. Background Information
    • 16.7.5. Government Initiatives
    • 16.7.6. Regulations
    • 16.7.7. Regulatory Bodies
    • 16.7.8. Major Associations
    • 16.7.9. Tax Levied
    • 16.7.10. Corporate Tax Structure
    • 16.7.11. Investments
    • 16.7.12. Major Companies
  • 16.8. USA Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 16.9. USA Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 16.10. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.11. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

17. South America Antiglaucoma Drugs Market

  • 17.1. South America Antiglaucoma Drugs Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Impact Of COVID-19
    • 17.1.3. Market Information
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Tax Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.3. South America Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.4. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.5. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.6. South America Antiglaucoma Drugs Market: Country Analysis
  • 17.7. Brazil Antiglaucoma Drugs Market
  • 17.8. Brazil Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 17.9. Brazil Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 17.10. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.11. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Middle East Antiglaucoma Drugs Market

  • 18.1. Middle East Antiglaucoma Drugs Market Overview
    • 18.1.1. Region Information
    • 18.1.2. COVID Impact
    • 18.1.3. Market Information
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 18.3. Middle East Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 18.4. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Africa Antiglaucoma Drugs Market

  • 19.1. Africa Antiglaucoma Drugs Market Overview
    • 19.1.1. Region Information
    • 19.1.2. COVID Impact
    • 19.1.3. Market Information
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Investments
    • 19.1.12. Major Companies
  • 19.2. Africa Antiglaucoma Drugs Market, Historic Market Growth, 2015 - 2019, Value ($ Million)
  • 19.3. Africa Antiglaucoma Drugs Market, Forecast Market Growth, 2019 - 2023, 2025F, 2030F Value ($ Million)
  • 19.4. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Global Antiglaucoma Drugs Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Allergen Plc.
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Novartis AG
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Santen Pharmaceutical Co., Ltd.
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial overview
  • 20.5. Akorn
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Pfizer
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Financial Overview

21. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

  • 21.1. Santen Pharmaceutical Acquired Eyevance Holdings LLC
  • 21.2. Aerie Pharmaceuticals Acquired Avizorex Pharma
  • 21.3. Santen Pharmaceuticals Co Ltd, Acquired InnFocus Inc.
  • 21.4. Santen Pharmaceutical Co., Ltd. Acquired Merck's Ophthalmology Products

22. Antiglaucoma Drugs Market, Pipeline Analysis

23. Antiglaucoma Drugs Market Opportunities And Strategies

  • 23.1. Global Antiglaucoma Drugs Market In 2023 - Countries Offering Most New Opportunities
  • 23.2. Global Antiglaucoma Drugs Market In 2023 - Segments Offering Most New Opportunities
  • 23.3. Global Antiglaucoma Drugs Market In 2023 - Growth Strategies
    • 23.3.1. Market Trend Based Strategies
    • 23.3.2. Competitor Strategies

24. Anti-Glaucoma Drugs Market, Conclusions And Recommendations

  • 24.1. Conclusions
  • 24.2. Recommendations
    • 24.2.1. Product
    • 24.2.2. Price
    • 24.2.3. Place
    • 24.2.4. Promotion

25. Appendix

  • 25.1. Market Data Sources
  • 25.2. Research Methodology
  • 25.3. Currencies
  • 25.4. Research Inquiries
  • 25.5. The Business Research Company
  • 25.6. Copyright And Disclaimer